Pharmaceutical giant Novavax has applied for authorization of its vaccine against Covid-19 in the European Union, the European Medicines Agency (EMA) announced on Tuesday, specifying that an opinion could be issued in "a
Read also Covid-19: what is Novavax, the new vaccine ordered by the European Commission?
The EMA has started to assess a conditional marketing authorization application for Novavax's anti-Covid vaccine
" said the European regulator in a
release, specifying that "
an opinion on the marketing authorization the market could be issued in a few weeks